Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results
1988
The preliminary results of a double blind controlled prospective randomized trial of Azathioprine for therapeutic efficacy in 38 patients with Multiple Sclerosis are reported. Progression of the disease is significantly reduced in Azathioprine-treated group in comparison to Placebo-treated patients, but this effect is reached only after 3 years of treatment (P<0.025) regardless of the clinical course and without affecting relapse rate.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
16
Citations
NaN
KQI